AlphAIAlphAI — Financial news for AI agents
SEC EDGARMAY 302 min read$THC

KERREY J ROBERT sold $341K of THC

KERREY J ROBERT sold 1,969 shares of TENET HEALTHCARE CORP (THC) at $173.12 ($0.34M total) on 2026-05-28.

Original reporting
SEC EDGAR · KERREY J ROBERT
Published May 30, 2026, 12:00 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI May 30, 2026, 12:01 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$THC
Neutral
medium confidence
Mentioned
$THC
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$THCNeutralLow
01

Why it matters

This disclosure updates insider ownership records but does not include any new operational, financial, or regulatory information about Tenet.

02

Market read

Traders may monitor for follow-on insider activity, but the filing alone is unlikely to drive a sustained repricing.

03

What to watch

Magnitude is modest relative to typical institutional float; insider sales often cluster around tax/portfolio events rather than earnings outlook.

Relevance 7/10Novelty 6/10Timing: Filed after-hours on 2026-05-29 for a sale dated 2026-05-28

Background

The article is an SEC Form 4 insider transaction disclosure for Tenet Healthcare (THC), reporting an open-market sale by a director.

Company-level read

Ticker impact

$THCNeutralMedium confidence
Context

Tenet Healthcare director KERREY J ROBERT sold 1,969 shares in an open-market transaction reported on SEC Form 4.

Expected impact

Low near-term impact; any reaction is likely muted unless followed by additional insider activity or new fundamentals.

Evidence & confidence

The filing is a routine Form 4 open-market sale with no 10b5-1 plan stated and no accompanying company-specific news.

Market effects

Sector

Minimal; single-insider Form 4 sale does not reset sector fundamentals for healthcare providers.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

The sale could be routine diversification or liquidity needs; without a 10b5-1 plan, it still may not imply negative expectations.

Key entities

  • issuer
    Tenet Healthcare Corp

    Subject of the Form 4 insider transaction disclosure.

  • insider
    KERREY J ROBERT

    Director who sold shares; transaction details are reported on SEC Form 4.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

THC insider trading history →

Related articles

SEP 9
$THCMedAI 8/10

What Tenet Healthcare (THC)'s $2b Debt Refinance Means For Shareholders

Tenet Healthcare (THC) priced a $2.0 billion private placement of 6.250% senior notes due 2034, upsized from $1.5 billion, to refinance existing 2027 and 2028 debt. The refinancing replaces secured and partly secured borrowings with unsecured notes, altering the company's debt structure. Investors focus on execution, pricing, and free cash flow, with high debt and earnings declines noted as risks.

simplywall.st2 min
SEP 9
$THCMedAI 8/10

Tenet Healthcare at Wells Fargo conference: high-acuity push deepens

Tenet Healthcare (THC) presented at the Wells Fargo Healthcare Conference, outlining a strategy focused on high-acuity care, capital spending, and cost control. The company raised full-year guidance, citing volume growth and cost discipline. Shares are near their 52-week high at $268.82, up over 30% year-to-date. Tenet expects continued pressure in some payer channels and near-term earnings drag from Conifer's transition. Management plans to invest in complex procedures and maintain capital spen

uk.investing.com2 min